Since the ’80s, a large body of research has indicated that estrogen impacts everything from cognition to mood to a person’s ...

Sleep disturbances, and intertwined anxiety, can follow you through the perimenopause period, which could last anywhere from ...

An in-depth analysis of ER+ breast cancer, focusing on its prevalence, molecular biology, current treatments, and emerging ...

Hone Health talks to medical experts who detail how shedding pounds is possible with a few smart diet and lifestyle tweaks.

A study finds that male rats in chronic pain escalate fentanyl use, while females maintain stable doses due to estrogen’s ...

PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...

The drug in question, called vepdegestrant, is an oral PROteolysis TArgeting Chimera (PROTAC) ER degrader. The phase 3 study ...

Trial results show vepdegestrant, a protein-degrading drug Arvinas is developing with Pfizer, improved on fulvestrant in a ...

New agents targeting endocrine therapy and CDK4/6 resistance in hormone receptor–positive breast cancer are in development.

Of course, science around estrogen and menopause—a noteworthy time of estrogen loss—is largely lacking: Research suggests that 99% of studies on the biology of aging leave menopausal subjects out.